The study for diagnostic value of Β-catenin immunohistochemistry marker in distinction of aggressive and non-aggressive basal cell carcinoma

(2019) The study for diagnostic value of Β-catenin immunohistochemistry marker in distinction of aggressive and non-aggressive basal cell carcinoma. Iranian Journal of Pathology. pp. 52-60. ISSN 17355303 (ISSN)

[img]
Preview
Text
10822.pdf

Download (1MB) | Preview

Abstract

Background & Objective: Basal cell carcinoma (BCC) is a common skin cancer arising from the basal layer of the epidermis and its appendages. They are locally invasive, aggressive, and destructive of skin and the surrounding structures. Β-Catenin is a multifunctional protein located to the intracellular side of the cytoplasmic membrane coded by the CTNNB1 gene, which maps to chromosome 3p22.1. It has a critical role in cell-to-cell adhesion by linking cadherins to the actin cytoskeleton and has a central role in transcriptional regulation in the Wnt signaling pathway. We evaluated the diagnostic value of the Beta catenin immunohistochemistry marker in distinction of aggressive and non-aggressive Basal cell carcinoma. Methods: This cross sectional and descriptive-analytical study was done on archived formalin fixed, paraffin embedded tissue blocks in pathology library of Al-Zahra hospital in Isfahan city. We used immunochemistry to determinate the role of Β-Catenin in aggressiveness in BCC with higher rate of relapse. Results: A total of 76 samples were evaluated in two groups (aggressive &none aggressive). The mean percentage of cytoplasmic Β-Catenin staining in aggressive group was more significant than the other group (sensitivity: 86.8 specificity: 81.6, PPV: 81.5 and NPV: 86.1) and the mean percentage of membranous Β-Catenin staining in non-aggressive group were significant more than the aggressive group. Intensity of membranous staining in both groups significant less than normal epithelium. Conclusion: Cytoplasmic Β-Catenin staining in aggressive BCC is more significant than non-aggressive subtypes, so this indicates that the use of Β-Catenin IHC marker maybe helpful in the diagnosis of aggressive BCC. © 2019, Iranian Society of Pathology. All rights reserved.

Item Type: Article
Keywords: Aggressive phase Basal cell Beta-catenin Carcinoma Sensitivity Specificity
Subjects: QZ Pathology > QZ 200-380 Neoplasms
WR Dermatology
Divisions: Faculty of Medicine > Departments of Clinical Sciences > Department of Internal
Faculty of Medicine > Departments of Clinical Sciences > Department of Pathology
Faculty of Medicine > Departments of Clinical Sciences > Department of Skin
Page Range: pp. 52-60
Journal or Publication Title: Iranian Journal of Pathology
Journal Index: Scopus
Volume: 14
Number: 1
Identification Number: https://doi.org/10.30699/IJP.14.1.52
ISSN: 17355303 (ISSN)
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/10822

Actions (login required)

View Item View Item